Does the alpha blocker Silodosin improve the bladder emptying in patients with MS?
- Conditions
- Multiple SclerosisMSneurogene blaasneurogenic bladderresidual urineurine residubladder residual volumeblaasresidualpha blockersalpha blokkers
- Registration Number
- NL-OMON26059
- Lead Sponsor
- Erasmus Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Female
-Age 18 years or older
Exclusion Criteria
-Dependency of wheel chair
-Being bedridden
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -Residual urine
- Secondary Outcome Measures
Name Time Method -Quality of life (questionnaire: SF-Qualiveen)<br /><br>-Symptom scores of voiding complaints (questionnaires: UDI-6 and IIQ-7)